Medications

Merck: New drugs pending approval or in late tests

Merck & Co. could get an impressive six new prescription medicines approved in the U.S. this year and will soon apply for regulatory approval of two others, company executives said Tuesday during a briefing on Merck's business.

May 06, 2014
popularity 5 / 5 (1) | comments 0